Türkeş, C. Et Al. 2016. In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum. Environmental Toxicology and Pharmacology , vol.42 , 252-257.

Türkeş, C., SÖYÜT, H., & BEYDEMİR, Ş., (2016). In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum. Environmental Toxicology and Pharmacology , vol.42, 252-257.

Türkeş, Cüneyt, HAKAN SÖYÜT, And ŞÜKRÜ BEYDEMİR. "In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum," Environmental Toxicology and Pharmacology , vol.42, 252-257, 2016

Türkeş, Cüneyt Et Al. "In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum." Environmental Toxicology and Pharmacology , vol.42, pp.252-257, 2016

Türkeş, C. SÖYÜT, H. And BEYDEMİR, Ş. (2016) . "In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum." Environmental Toxicology and Pharmacology , vol.42, pp.252-257.

@article{article, author={Cüneyt Türkeş Et Al. }, title={In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum}, journal={Environmental Toxicology and Pharmacology}, year=2016, pages={252-257} }